Amishi Desai, | |
1500 Route 112 Bldg 4, Port Jefferson Station, NY 11776-8055 | |
(631) 751-3000 | |
(631) 509-6559 |
Full Name | Amishi Desai |
---|---|
Gender | Female |
Speciality | Hematology |
Experience | 15 Years |
Location | 1500 Route 112 Bldg 4, Port Jefferson Station, New York |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1902141914 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RH0003X | Internal Medicine - Hematology & Oncology | 283677 (New York) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Good Samaritan Hospital Medical Center | West islip, NY | Hospital |
Ns/lij Hs Southside Hospital | Bay shore, NY | Hospital |
Long Island Community Hospital | Patchogue, NY | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
North Shore Hematology Oncology Associates Pc | 1456243641 | 314 |
News Archive
ACOs continue to hold attention, with the administration's rule expected this week. Meanwhile, other reform news includes reports about health exchanges and a medical device tax.
South African public health experts from Medecins San Frontieres (MSF) South Africa and the Treatment Action Campaign (TAC) "are calling on governments to use legally available mechanisms to promote the production or import of generic drugs in their countries," Inter Press Service reports.
The first test to identify acute mountain sickness has been developed by a team of researchers in Italy and France and is presented today at EuroEcho-Imaging 2013. The test could revolutionise trekking and climbing by predicting who will develop the potentially deadly condition so they can avoid high altitudes, ascend more gradually or take preventative medication.
Titan Pharmaceuticals, Inc. today announced that data from its previously completed and announced Phase 3 randomized, placebo-controlled clinical trial of Probuphine were published in the Journal of the American Medical Association (JAMA).
› Verified 2 days ago
Entity Name | Department Of Medicine Medical Serv Grp At Suny Hlth Sci Ctr Syr In |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1063468239 PECOS PAC ID: 3274445796 Enrollment ID: O20031104000051 |
News Archive
ACOs continue to hold attention, with the administration's rule expected this week. Meanwhile, other reform news includes reports about health exchanges and a medical device tax.
South African public health experts from Medecins San Frontieres (MSF) South Africa and the Treatment Action Campaign (TAC) "are calling on governments to use legally available mechanisms to promote the production or import of generic drugs in their countries," Inter Press Service reports.
The first test to identify acute mountain sickness has been developed by a team of researchers in Italy and France and is presented today at EuroEcho-Imaging 2013. The test could revolutionise trekking and climbing by predicting who will develop the potentially deadly condition so they can avoid high altitudes, ascend more gradually or take preventative medication.
Titan Pharmaceuticals, Inc. today announced that data from its previously completed and announced Phase 3 randomized, placebo-controlled clinical trial of Probuphine were published in the Journal of the American Medical Association (JAMA).
› Verified 2 days ago
Entity Name | North Shore Hematology Oncology Associates Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1396794574 PECOS PAC ID: 1456243641 Enrollment ID: O20040324001766 |
News Archive
ACOs continue to hold attention, with the administration's rule expected this week. Meanwhile, other reform news includes reports about health exchanges and a medical device tax.
South African public health experts from Medecins San Frontieres (MSF) South Africa and the Treatment Action Campaign (TAC) "are calling on governments to use legally available mechanisms to promote the production or import of generic drugs in their countries," Inter Press Service reports.
The first test to identify acute mountain sickness has been developed by a team of researchers in Italy and France and is presented today at EuroEcho-Imaging 2013. The test could revolutionise trekking and climbing by predicting who will develop the potentially deadly condition so they can avoid high altitudes, ascend more gradually or take preventative medication.
Titan Pharmaceuticals, Inc. today announced that data from its previously completed and announced Phase 3 randomized, placebo-controlled clinical trial of Probuphine were published in the Journal of the American Medical Association (JAMA).
› Verified 2 days ago
Mailing Address | Practice Location Address |
---|---|
Amishi Desai, 1500 Route 112 Bldg 4, Port Jefferson Station, NY 11776-8055 Ph: (631) 751-3000 | Amishi Desai, 1500 Route 112 Bldg 4, Port Jefferson Station, NY 11776-8055 Ph: (631) 751-3000 |
News Archive
ACOs continue to hold attention, with the administration's rule expected this week. Meanwhile, other reform news includes reports about health exchanges and a medical device tax.
South African public health experts from Medecins San Frontieres (MSF) South Africa and the Treatment Action Campaign (TAC) "are calling on governments to use legally available mechanisms to promote the production or import of generic drugs in their countries," Inter Press Service reports.
The first test to identify acute mountain sickness has been developed by a team of researchers in Italy and France and is presented today at EuroEcho-Imaging 2013. The test could revolutionise trekking and climbing by predicting who will develop the potentially deadly condition so they can avoid high altitudes, ascend more gradually or take preventative medication.
Titan Pharmaceuticals, Inc. today announced that data from its previously completed and announced Phase 3 randomized, placebo-controlled clinical trial of Probuphine were published in the Journal of the American Medical Association (JAMA).
› Verified 2 days ago
Dr. Michael W Mendelson, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 5360 Nesconset Hghy, Suite B, Port Jefferson Station, NY 11776 Phone: 631-331-3200 Fax: 631-331-3694 | |
Matias M Dcosta, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 931 Hallock Ave, Port Jefferson Station, NY 11776 Phone: 631-331-7200 Fax: 631-331-8636 | |
Dr. Iryna Ilyasova, M.D Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1500 Route 112 Ste A, Port Jefferson Station, NY 11776 Phone: 631-686-1414 | |
Kinjal Amit Gosalia, STUDENT Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 5316 Nesconset Hwy, Port Jefferson Station, NY 11776 Phone: 631-758-7003 Fax: 631-751-0506 | |
Zarlasht Khan, Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1500 Route 112, Port Jefferson Station, NY 11776 Phone: 631-743-6840 | |
Anil Sangwan, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 116 Terryville Rd, Port Jefferson Station, NY 11776 Phone: 631-928-2002 Fax: 631-473-4427 | |
Anish Desai, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1500 Route 112 Ste B, Port Jefferson Station, NY 11776 Phone: 631-978-7633 Fax: 631-621-4119 |